Research Topics
Genomes and GenesSpecies | Richard J CaselliSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic interventionRichard J Caselli
Department of Neurology, Mayo Clinic Phoenix, AZ 85259, USA
J Alzheimers Dis 33:S405-16. 2013....
Phenotypic differences between apolipoprotein E genetic subgroups: research and clinical implicationsRichard J Caselli
Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
Alzheimers Res Ther 4:20. 2012..To date, this has impacted study design in some research trials but not clinical practice...
Longitudinal modeling of cognitive aging and the TOMM40 effectRichard J Caselli
Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA
Alzheimers Dement 8:490-5. 2012..To assess the possible contribution of TOMM40 to Alzheimer's disease onset, we compared the effects of TOMM40 and APOE genotype on preclinical longitudinal memory decline...
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesR J Caselli
Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
Neurology 76:1078-84. 2011..To characterize the effects of cerebrovascular (CV) risk factors on preclinical memory decline in cognitively normal individuals at 3 levels of genetic risk for Alzheimer disease (AD) based on APOE genotype...
Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairmentRichard J Caselli
Department of Neurology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
Arch Neurol 65:1231-6. 2008....
Alzheimer's disease a century laterRichard J Caselli
Department of Neurology, Mayo Clinic and Arizona Alzheimer s Disease Consortium, Scottsdale 85259, USA
J Clin Psychiatry 67:1784-800. 2006..To provide a current survey of the clinical and pathologic features, known genetic and suggested pathogenic contributions, diagnosis, and treatment of Alzheimer's disease (AD) and related forms of dementia...
Age-related memory decline and apolipoprotein E e4Richard J Caselli
Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
Discov Med 8:47-50. 2009..These results correlate with imaging and neuropathological studies that show AD-like changes at this age and collectively support the existence of a presymptomatic stage of AD...
Medical management of frontotemporal dementiaRichard J Caselli
Department of Neurology, Mayo Clinic and Arizona Alzheimer s Disease Consortium, Scottsdale, Arizona 85259, USA
Am J Alzheimers Dis Other Demen 22:489-98. 2007..In addition to pharmacotherapy, important lifestyle issues confronting the clinician include driving cessation, securing any weapons maintained at home, assisted living, and caregiver burnout...
Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 alleleR J Caselli
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, AZ 85259, USA
Neurology 62:1990-5. 2004..To determine whether memory loss is detectable before the symptomatic presentation of mild cognitive impairment (MCI) in those at greater genetic risk for Alzheimer disease (AD) based upon presence or absence of the e4 allele of APOE...
Amyloid load in nondemented brains correlates with APOE e4Richard J Caselli
Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Blvd, Scottsdale, AZ 85259, United States
Neurosci Lett 473:168-71. 2010..Nondemented APOE e4 carriers over age 60 have a higher burden of total parenchymal and vascular amyloid neuropathology than NC, but no difference in neuritic plaque and NFT pathology...
Progressive aphasia with Lewy bodiesRichard J Caselli
Department of Neurology, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, AZ 85259, USA
Dement Geriatr Cogn Disord 14:55-8. 2002....
A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotesRichard J Caselli
Department of Neurology, Mayo Clinic Scottsdale, University of Arizona, 85259, USA
Sleep 25:447-53. 2002..To correlate memory measures with a trait measure of chronic daytime somnolence in cognitively normal individuals with different gene doses of the apolipoprotein E (APOE) e4 allele, a common Alzheimer's disease susceptibility gene...
Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairmentRichard J Caselli
Department of Neurology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
Arch Neurol 64:1306-11. 2007..These changes could represent presymptomatic disease in some, despite their youth...
A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behaviorRichard J Caselli
Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
Sleep 29:927-33. 2006..To test the hypothesis that healthy adults reporting dream-enactment behavior (DEB+) have reduced cerebral metabolic rate for glucose (CMRgl) in regions preferentially affected in patients with dementia with Lewy bodies (DLB)...
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effectRichard J Caselli
Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA
N Engl J Med 361:255-63. 2009..The age at which memory decline diverges among persons who are homozygous for the APOE epsilon4 allele, those who are heterozygous for the allele, and noncarriers is unknown...
Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication studyR J Caselli
Department of Neurology, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
J Neurol Sci 189:93-8. 2001....
Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriersR J Caselli
Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
Neurology 76:1383-8. 2011..pole/neocortex, and posterior cingulate by age 65 years in APOE ε4 carriers prior to the diagnosis of mild cognitive impairment (MCI) and Alzheimer disease (AD), but is it impairing frontally mediated neuropsychological performance?..
Creativity: an organizational schemaRichard J Caselli
Department of Neurology, Mayo Clinic, AZ 85259, USA
Cogn Behav Neurol 22:143-54. 2009..To describe an organizational schema of human creativity...
A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotesRichard J Caselli
Department of Neurology, Mayo Clinic Scottsdale, University of Arizona, AZ, USA
J Neuropsychiatry Clin Neurosci 16:320-9. 2004..Chronic anxiety adversely affects cognitive skills in all groups, and is associated with significantly greater decline in problem solving skills in cognitively normal APOE e4 HMZ...
Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 alleleJessica B S Langbaum
Banner Alzheimer s Institute, 901 E Willetta St, Phoenix, AZ 85006, USA
Arch Neurol 67:462-8. 2010....
Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathologyWinnie S Liang
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA
Neurobiol Aging 31:549-66. 2010..We also provide this high-quality, low post-mortem interval (PMI), cell-specific, and region-specific NDAD/AD reference data set to the community as a public resource...
Evidence for an association between KIBRA and late-onset Alzheimer's diseaseJason J Corneveaux
Translational Genomics Research Institute TGen, Neurogenomics Division, Phoenix, AZ 85004, USA
Neurobiol Aging 31:901-9. 2010..034; OR=1.29) and in a combined analysis of 1026 additional living and expired subjects (P=0.039; OR=1.26). Our findings suggest that KIBRA is associated with both individual variation in normal episodic memory and predisposition to AD...
Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal agingEric M Reiman
Banner Alzheimer s Institute and Banner Good Samaritan PET Center, 901 East Willetta Street, Phoenix, AZ 85006, USA
Neuroimage 49:169-76. 2010..We propose using PET in proof-of-concept randomized controlled trials to rapidly evaluate the effects of midlife cholesterol-lowering treatments on the brain changes associated with normal aging and AD...
Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy ratesKewei Chen
Banner Alzheimer Institute, Banner Good Samaritan PET Center, 1111 E McDowell Rd, Phoenix, AZ 85006, USA
Am J Psychiatry 164:916-21. 2007..The authors previously found accelerated whole brain atrophy rates in patients with probable Alzheimer's disease by computing changes in brain volume from sequential magnetic resonance images (MRIs)...
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolismEric M Reiman
Positron Emission Tomography Center, Banner Good Samaritan Medical Center, Phoenix, AZ 85006, USA
Proc Natl Acad Sci U S A 102:8299-302. 2005..This study raises the possibility of using PET as a quantitative presymptomatic endophenotype to help evaluate the individual and aggregate effects of putative genetic and nongenetic modifiers of AD risk...
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data setWinnie S Liang
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA
Physiol Genomics 33:240-56. 2008..We provide this carefully phenotyped, laser capture microdissected intraindividual brain region expression data set to the community as a public resource...
Development of methodology for conducting clinical trials in frontotemporal lobar degenerationDavid S Knopman
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Brain 131:2957-68. 2008..There are several candidate outcome measures -- including the FTLD-CDR and the cognitive composites -- that could be used in clinical trials across the spectrum of FTLD...
Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regionsEric M Reiman
Banner Alzheimer s Institute and Banner Good Samaritan PET Center, Phoenix, AZ 85006, USA
Neuroimage 40:1214-21. 2008..The results support the role of cholesterol-related genes in the predisposition to AD and support the value of neuroimaging in the presymptomatic assessment of putative modifiers of AD risk...
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementiaEric M Reiman
Positron Emission Tomography Center, Banner Good Samaritan Medical Center, Phoenix, AZ 85006, USA
Proc Natl Acad Sci U S A 101:284-9. 2004..Carriers of a common Alzheimer's susceptibility gene have functional brain abnormalities in young adulthood, several decades before the possible onset of dementia...
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriersWinnie S Liang
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA
Neuroimage 54:1896-902. 2011..It also supports the use of brain-imaging endophenotypes to help assess possible modifiers of AD risk...
Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriersCynthia M Stonnington
Division of Adult Psychiatry, Mayo Clinic, Scottsdale, AZ 85259, USA
J Clin Psychiatry 70:1379-84. 2009..To examine cognitive effects of pharmacologically induced somnolence in cognitively normal carriers and noncarriers of the apolipoprotein E (APOE)-epsilon4 allele, a common Alzheimer's disease susceptibility gene...
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseEric M Reiman
Banner Alzheimer s Institute and the Positron Emission Tomography Center, Good Samaritan Regional Medical Center, Phoenix, AZ 85006, USA
Proc Natl Acad Sci U S A 106:6820-5. 2009....
Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age personsJessica B S Langbaum
Banner Alzheimer s Institute, Phoenix, AZ 85006, USA
Neurobiol Aging 33:827.e11-9. 2012..These preliminary findings provide additional evidence that higher BP, likely a reflection of arterial stiffness, during late midlife may be associated with increased risk of presymptomatic AD...
Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaireDona E C Locke
Division of Psychology, Mayo Clinic, Scottsdale, AZ 85259, USA
Dement Geriatr Cogn Disord 27:260-72. 2009..To provide preliminary validation data on a self- or informant-report multidimensional questionnaire of symptoms associated with neurodegenerative disorders...
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementiaAmy C Almaraz
Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
Neurologist 15:234-7. 2009..Therefore, cholinesterase inhibitors might improve cognitive function in PDD. On the other hand, enhancing cholinergic function could plausibly worsen features of parkinsonism...
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squaresKewei Chen
Banner Alzheimer s Institute and Banner Good Samaritan PET Center, Phoenix, AZ, USA
Neuroimage 60:2316-22. 2012..7 × 10(-4)). Our findings support the possibility of using the MMPLS to analyze complementary datasets from the same person in the presymptomatic detection and tracking of AD...
Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's diseaseLeslie C Baxter
Neuropsychology Neuroimaging Laboratory, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, 222 W Thomas Rd, Suite 310, Phoenix, AZ 85013, USA
Neurobiol Aging 24:947-52. 2003..This suggests that longitudinal study of new learning is a sensitive measure for detecting early cognitive changes in at-risk individuals that precede the symptomatic onset of mild cognitive impairment and AD...
Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topicGretchen E Schlosser Covell
Department of Neurology, Division of Education Administration, Mayo Clinic, Scottsdale, AZ, USA
Neurologist 18:426-9. 2012..Most of these studies have been cross-sectional, and often look at patients already with dementia. This leaves uncertainty with regard to the temporal relationship of circadian disruption and cognitive decline...
Apolipoprotein E and intellectual achievementRichard J Caselli
Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
J Am Geriatr Soc 50:49-54. 2002..To determine whether apolipoprotein E (apo E) genotype influences intellectual achievement in cognitively normal individuals...
Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive agingDona E C Locke
Department of Psychiatry and Psychology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
J Clin Exp Neuropsychol 33:937-43. 2011..We encourage investigators involved in longitudinal studies to consider causes for missing data, especially when secondary to participant refusal...
Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility geneJon Valla
Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, AZ, USA
J Alzheimers Dis 22:307-13. 2010..This functional biomarker may prove useful in early detection and tracking of AD and indicates that mitochondrial mechanisms may contribute to the predisposition to AD before any evidence of amyloid or tau pathology...
Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topicKatherine C Riordan
Department of Neurology, Mayo Clinic, Mayo Clinic Hospital, Phoenix, AZ 85054, USA
Neurologist 17:121-3. 2011..Evidence that the use of memantine in a patient already on cholinesterase inhibitor therapy can provide a clinically significant benefit is limited...
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriersEric M Reiman
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Neuron 54:713-20. 2007..Our findings suggest that GAB2 modifies LOAD risk in APOE epsilon4 carriers and influences Alzheimer's neuropathology...
Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adultsGene E Alexander
Department of Psychology, University of Arizona, Tucson, AZ 85721, USA
Neurobiol Aging 33:2723-32. 2012....
Linking functional and structural brain images with multivariate network analyses: a novel application of the partial least square methodKewei Chen
Banner Alzheimer s Institute and the Banner Good Samaritan PET Center, Phoenix, AZ 85006, USA
Neuroimage 47:602-10. 2009....
Anxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriersCynthia M Stonnington
Dept of Psychiatry and Psychology, Section of Biostatistics, and Dept of Neurology, Mayo Clinic, Arizona, USA
J Neuropsychiatry Clin Neurosci 23:294-9. 2011..The association of executive-functioning difficulties and anxiety appears more likely to occur in persons who are most at risk for subsequent cognitive decline...
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatmentsEric M Reiman
Banner Alzheimer s Institute, Phoenix, AZ 85006, USA
J Alzheimers Dis 26:321-9. 2011....
Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case seriesFarrah J Mateen
Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
Neurocase 18:1-12. 2012....
Current issues in the diagnosis and management of dementiaRichard J Caselli
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
Semin Neurol 23:231-40. 2003..Mild cognitive impairment, topography and semiology of dementia syndromes, reversible forms of dementia, dementia therapy, driving, genetic testing of patients and family members, and caregiver risk are reviewed...
Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelinationReem F Bunyan
Department of Neurology, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA
Arch Neurol 68:525-8. 2011..To describe a case of childhood-onset progressive multiple sclerosis with dementia and evidence of extensive cortical demyelination from brain biopsy specimen...
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophyD F Tang-Wai
Department of Neurology, Mayo Alzheimer s Disease Research Center, Rochester, MN, USA
Neurology 63:1168-74. 2004..To examine the clinical, genetic, and neuropathologic features of posterior cortical atrophy (PCA)...
Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 casesMark K Lyons
Department of Neurological Surgery, Mayo Clinic Arizona, Phoenix, AZ 85054, USA
J Neurosurg 108:1024-7. 2008..This procedure is important because NAIM can be treated successfully if it is distinguished from the nontreatable dementias that mimic it...
Off-label medication use in frontotemporal dementia- Bei Hu
Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA 94143, USA
Am J Alzheimers Dis Other Demen 25:128-33. 2010..We sought to determine the most commonly used drugs used to treat behavioral variant FTD (bvFTD) in specialized dementia clinics...
"Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseasesMark G Hickey
Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, Arizona 85259, USA
Neurologist 13:98-101. 2007..To determine whether a diagnosis of idiopathic rapid-eye-movement sleep behavior disorder (RBD) is associated with a future risk of development of neurodegenerative diseases...
Motor unit number estimates in idiopathic Parkinson's diseaseJ N Caviness
Department of Neurology, Mayo Clinic Scottsdale, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
Parkinsonism Relat Disord 8:161-4. 2002..Progress in decreasing the variance of MUNEs will facilitate their use in detecting small motor unit number changes in neurodegenerative disease...
Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathologyB F Boeve
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Dement Geriatr Cogn Disord 13:80-90. 2002....
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 yearD S Knopman
Department of Neurology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Neurology 72:1843-9. 2009..Because there is only limited longitudinal imaging data currently available, we measured the rate of change over 1 year of whole brain volume (WBV) and ventricular volume (VV) in patients with FTLD...
Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob diseaseC Hoffman Snyder
Department of Neurology, Mayo Clinic Arizona, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
Arch Neurol 63:766-8. 2006....
Electrophysiology of the myoclonus in dementia with Lewy bodiesJ N Caviness
Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA
Neurology 60:523-4. 2003
APOE and neuroenergetics: an emerging paradigm in Alzheimer's diseaseAndrew B Wolf
Department of Biochemistry, Midwestern University, Glendale, AZ, USA Arizona Alzheimer s Consortium, Phoenix, AZ, USA
Neurobiol Aging 34:1007-17. 2013..This research might lead to the identification of novel therapeutic targets for the treatment and/or prevention of Alzheimer's disease...
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brainWinnie S Liang
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA
Physiol Genomics 28:311-22. 2007..These neuronal profiles will provide valuable reference information for future studies of the brain, in normal aging, AD and other neurological and psychiatric disorders...
Autoimmune encephalopathyEoin P Flanagan
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
Semin Neurol 31:144-57. 2011..Paraneoplastic syndromes typically require tumor removal and often prove fatal. CNS vasculitides may respond to steroid therapy, but often require a second agent such as cyclophosphamide...
Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patientsSara L P Schrader
Department of Neurology, Division of Education Administration, Mayo Clinic, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
Neurologist 14:134-7. 2008..More effective preventive strategies could notably impact morbidity, mortality, and health care costs...
Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observationsJohn N Caviness
Parkinson s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
Mov Disord 17:657-62. 2002..Although the myoclonus occurred without dementia in these cases, its relationship to the subsequent development of cognitive impairment remains to be defined...
Longitudinal tracking of FTLD: toward developing clinical trial methodologyDavid S Knopman
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Alzheimer Dis Assoc Disord 21:S58-63. 2007..In addition, a multicenter trial is described in which some aspects of diagnosis and longitudinal measurement in the frontotemporal lobar degenerations are being specifically explored...
Myoclonus in Lewy body disordersJohn N Caviness
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Adv Neurol 89:23-30. 2002
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's diseaseE M Reiman
Department of Psychiatry, University of Arizona, Tucson, AZ 85724, USA
Proc Natl Acad Sci U S A 98:3334-9. 2001....
Patterns of brain atrophy in clinical variants of frontotemporal lobar degenerationPo H Lu
Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, Calif, USA
Dement Geriatr Cogn Disord 35:34-50. 2013..More specifically, the bvFTD group showed significant white matter contraction and presence of behavioral symptoms at baseline predicted significant volume loss of the ventromedial prefrontal cortex...
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementiaRosa Rademakers
Department of Neuroscience, Mayo Clinic, Jacksonville, FL FL 32224, USA
Hum Mol Genet 17:3631-42. 2008..Translational regulation by miRNAs may represent a common mechanism underlying complex neurodegenerative disorders...
The treatable dementia of Sjögren's syndromeR J Caselli
Department of Neurology, Mayo Clinic, Rochester, MN
Ann Neurol 30:98-101. 1991..Treatment with high-dose corticosteroids produced rapid and nearly complete resolution of the dementia...
Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotypeNicola J Rutherford
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Neurobiol Aging 33:2950.e5-7. 2012..No meaningful association between the repeat length of the normal alleles of the GGGGCC repeat in C9ORF72 and disease phenotype or age at onset was observed in C9ORF72 mutation carriers or nonmutation carriers...
Giant cell arteritisTodd J Schwedt
Washington University School of Medicine, Department of Neurology, 660 South Euclid Avenue, Campus Box 8111, St Louis, MO 63110, USA
Curr Pain Headache Rep 10:415-20. 2006..Prompt treatment with corticosteroids is essential in order to minimize the frequency of permanent sequelae such as visual loss and stroke...
Alzheimer's diseaseE M Reiman
Department of Psychiatry, University of Arizona, Tucson, USA
Maturitas 31:185-200. 1999....
Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairmentSterling C Johnson
Geriatric Research Education and Clinical Center, Wm S Middleton VA Hospital, Madison, WI 53705, USA
Neuropsychologia 42:980-9. 2004..Results suggest that the medial temporal response over repeated presentation is related to clinical status. Probes of incremental encoding processes over trials may be useful markers of medial temporal lobe integrity...
Cognitive frailty: Predementia syndrome and vascular risk factorsFrancesco Panza
Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
Neurobiol Aging 27:933-40. 2006..This review will focus on the possible role of vascular risk factors in modulating the risk of age-related cognitive decline, and the progression of predementia syndrome such as MCI to dementia...
Current epidemiology of mild cognitive impairment and other predementia syndromesFrancesco Panza
Dept of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Italy
Am J Geriatr Psychiatry 13:633-44. 2005..To clarify the sources of discrepant findings in the literature, this review summarizes existing epidemiological studies of the defined clinical predementia syndromes and their progression to dementia...
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on agingFrancesco Panza
Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Italy
Dement Geriatr Cogn Disord 25:336-46. 2008..We evaluated the impact of depressive symptoms on the rate of incident mild cognitive impairment (MCI) after a 3.5-year follow-up, and we assessed the interaction between depressive symptoms and vascular risk factors for incident MCI...
Regional network of magnetic resonance imaging gray matter volume in healthy agingGene E Alexander
Neuroimage Analysis Laboratory, Department of Psychology, Arizona State University, Tempe, AZ 85287 1104, USA
Neuroreport 17:951-6. 2006..Scaled Subprofile Model network analysis may aid in the detection and tracking of brain aging and in the evaluation of putative antiaging therapies...
Common Kibra alleles are associated with human memory performanceAndreas Papassotiropoulos
Division of Psychiatry Research, University of Zurich, Zurich 8057, Switzerland
Science 314:475-8. 2006..Functional magnetic resonance imaging detected KIBRA allele-dependent differences in hippocampal activations during memory retrieval. Evidence from these experiments suggests a role for KIBRA in human memory...
Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitnessJennifer L Etnier
Department of Exercise and Sport Science, University of North Carolina, Greensboro, NC 27402, USA
Med Sci Sports Exerc 39:199-207. 2007..Apolipoprotein E (ApoE) genotype and aerobic fitness are each associated with cognitive performance in older adults. However, their potentially interactive effects on cognitive performance have not been examined...
Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on agingVincenzo Solfrizzi
Memory Unit, Center for Aging Brain, Department of Geriatrics, University of Bari, Bari, Italy
Dement Geriatr Cogn Disord 24:55-64. 2007..We estimated the prevalence and incidence rates of depressive symptoms and the role of vascular risk factors and sociodemographic variables on the occurrence of depressive symptoms in mild cognitive impairment (MCI)...
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosisNicola J Rutherford
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America
PLoS Genet 4:e1000193. 2008....
Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjectsDouglas A Hinerfeld
Arch Neurol 64:1672-3. 2007
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphismsStacey Melquist
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Am J Hum Genet 80:769-78. 2007..Since DNA damage and lysosomal dysfunction have been implicated in aging and neurodegenerative processes, both genes are viable candidates for conferring risk of disease...
Cognitive impairment, frontotemporal dementia, and the motor neuron diseasesMichael J Strong
Department of Clinical Neurological Sciences and the Robarts Research Institute, London, Ontario, Canada
Ann Neurol 54:S20-3. 2003
January 16 highlight and commentary: subspecialization within somatosensory cortexRichard J Caselli
Neurology 68:1955; author reply 1955-6. 2007
